Aurora Cannabis Inc vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Aurora Cannabis Inc trades at $3.77 (market cap $223.59M), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $124.19. The key difference: Direxion NASDAQ 100 Equal Weighted Index Shares is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| ACB | QQQE | |
|---|---|---|
Market Cap | $223.59M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $6.23 | $123.14 |
52-Week Low | $2.58 | $96.06 |
Enterprise Value | $168.09M | — |
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $3.82, up 32.18% amid Curaleaf's hostile takeover bid offering a 45% premium. The stock shows mixed technical signals with neutral RSI but bearish moving averages. Fundamentally, ACB achieved profitability in 2025 with $1.59M net income after years of losses, though 2026 projections show renewed negative margins. Revenue grew 27% year-over-year to $343M, but the company faces significant execution risks in a competitive cannabis market.
The takeover bid creates near-term upside potential to $4 per share, but standalone prospects remain challenged by negative profitability projections and competitive pressures. Investors face a binary outcome: accept the premium offer or risk ACB's volatile standalone execution amid declining 2026 revenue and negative margins.
QQQE (Direxion NASDAQ-100 Equal Weighted Index ETF) trades at $123.14, up 0.81% with a bullish technical signal from moving averages. The ETF provides equal-weighted exposure to Nasdaq-100 companies, reducing concentration risk compared to market-cap weighted alternatives. Recent news highlights SpaceX's potential inclusion in the index, which could drive additional inflows. Technical indicators show strong momentum with ADX readings above 25, though RSI suggests some overbought conditions near-term.
The equal-weight approach offers defensive positioning against tech concentration risks while maintaining Nasdaq growth exposure. Key catalysts include continued tech sector strength and index rebalancing benefits. Risks involve Nasdaq volatility and potential sector rotation away from growth stocks. The ETF's structure provides diversification benefits for investors seeking balanced Nasdaq exposure.
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →